Chemotherapy is the use of drugs to target rapidly growing cells in an effort to destroy cancer cells. Chemotherapy drugs kill healthy cells as well as cancer cells. The drug is referred to as systemic, since it travels through the entire body. Chemotherapy medications may be given through the vein (intravenously) or by mouth (orally). Because chemotherapy drugs affect all rapidly-dividing cells in the body (not just cancer cells), these drugs may have severe side effects. Common side effects of chemotherapy include fatigue, nausea, hair loss, and trouble concentrating. Peripheral neuropathy, or nerve damage, may occur as well.
Targeted therapies or precision medicines are designed to block a specific target, usually a protein or genetic change, that can influence the growth and development of cancer cells. Since targeted therapies directly attack the cancer cells, they tend to have less side effects than traditional medications such as chemotherapy, which target all rapidly-dividing cells.
The two main types of targeted therapy are small-molecule drugs and monoclonal antibodies.
Immunotherapy is a new cancer treatment that stimulates the body's immune system to attack cancer cells. Monoclonal antibodies are considered a type of immunotherapy, as well as a type of targeted therapy, because these medications cause the immune system to target and destroy cancer cells. Another type of immunotherapy is immune checkpoint inhibitors. The immune system has "checkpoints," which are proteins that bind to cells and tell the immune system to attack the cells or leave them alone. Sometimes cancer cells can have large amounts of these checkpoint proteins, causing the immune system to ignore them. Immune checkpoint inhibitors block these checkpoints and signal the immune system to attack the cancer cells. Two other common types of immunotherapy are interferons and interleukins. Interferons stimulate the immune system to fight cancer or infections. Interleukins help immune cells to grow and reproduce quickly. Cancer vaccines are uncommon, but are currently being studied in clinical trials.
Each of these types of drugs may be combined with one another, or with other cancer treatments such as chemotherapy and/or radiation therapy. In some cases, cancer cells can become resistant to chemotherapy or targeted therapy, and combinations of treatments may be recommended.